Schon Labs Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 11 Year, 5 Months
- Last Filing with ROC 31 Mar 2019
- Revenue Growth 11515.51%
- Profit Growth 482.50%
- Ebitda -285.34%
- Net Worth 178.24%
- Total Assets 68.62%
About Schon Labs
Schon Labs Private Limited (SLPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 28 August 2013 and has a history of 11 years and five months. Its registered office is in Hyderabad, Telangana, India.
The Corporate was formerly known as Koncept Labels Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2019. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Belide Naveen, Bodapati Kumar, and Sudheer Kankanala serve as directors at the Company.
Company Details
-
Location
Hyderabad, Telangana, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U73100TG2013PTC089705
-
Company No.
089705
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
28 Aug 2013
-
Date of AGM
30 Sep 2019
-
Date of Balance Sheet
31 Mar 2019
-
Listing Status
Unlisted
-
ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Schon Labs?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Belide Naveen
|
Additional Director | 23-Nov-2019 | Current |
|
Bodapati Kumar
|
Director | 23-Oct-2018 | Current |
|
Sudheer Kankanala
|
Director | 23-Oct-2018 | Current |
Financial Performance of Schon Labs.
Schon Labs Private Limited, for the financial year ended 2019, experienced significant growth in revenue, with a 11515.51% increase. The company also saw a substantial improvement in profitability, with a 482.5% increase in profit. The company's net worth Soared by an impressive increase of 178.24%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Schon Labs?
In 2018, Schon Labs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Astal Laboratories LimitedSudheer Kankanala is a mutual person
-
Shakthisri Bio Crop Sciences Private LimitedBelide Naveen is a mutual person
-
Crosol Crop Care Private Limited
Belide Naveen is a mutual person
-
Alsys Research Llp
Sudheer Kankanala is a mutual person
-
Kasner Bio Llp
Sudheer Kankanala is a mutual person
-
Zeugen Technologies Private Limited
Sudheer Kankanala is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Schon Labs?
Unlock and access historical data on people associated with Schon Labs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Schon Labs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Schon Labs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
